The Latest Life Sciences Tools & Diagnostics Articles from Streetwise Reports


Technical Analyst Expects Health Technologies Firm to Break Higher

Contributed Opinion
  ()
Technical analyst Clive Maund outlines the reasons this stock might break higher. read more >

Guardant Health Reports Quarterly Revenue Up 178%

  ()
Guardant Health Inc. reported strong growth for Q2/19 versus the same period last year and raised its full-year 2019 revenue guidance to $180190 million. read more >

Biotech's Mosquito Test 'Gains Market Acceptance'

Research Report
  ()
This West Nile virus test and others including cancer diagnostic tests in the Utah company's pipeline are discussed in an H.C. Wainwright & Co. report. read more >

Tandem Increases Unit Sales of t:slim X2 Insulin Pumps 290% Worldwide

  ()
Tandem Diabetes Care's second quarter earnings highlighted a 290% increase in unit sales of its t:slim X2 insulin pumps that feature integrated continuous glucose monitoring and remote software update capability. read more >

Technical Analyst: Medical Device Stock Looking Set to Reverse

Contributed Opinion
  ()
Technical analyst Clive Maund charts the stock of this company that has developed a device that uses a special light that visualizes cancer during minimally invasive surgery. read more >

Health Technology Company Recuperating Well

Contributed Opinion
  ()
Technical analyst Clive Maund charts a medical technology firm and explains why he believes it is an interesting speculative play. read more >

Bacteria Test Developer Reiterates Revenue Should Double in 2019

Research Report
  ()
The product expected to drive that outcome is discussed in an H.C. Wainwright & Co. report. read more >
News Update

Healthcare Firm Partners on Genetic Testing for Cannabis, Medication Responses

News Update
  ()
The offering should facilitate a more individualized treatment plan for patients. read more >
News Update

Health Tech Firm to Pilot Artificial Intelligence-Powered Patient Monitoring Tool

News Update
  ()
This effort is one way the company can innovatively offer patients care. read more >
Showing Results: 1 to 9 of 9

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts

"GSV's South Railroad project has an after-tax NPV5% of $241.5M."
– Brien Lundin, Gold Newsletter (Jefferson Financial)
"GBR seems likely to continue providing bullish news on a regular basis."
– Brien Lundin, Gold Newsletter (Jefferson Financial)
"We are maintaining our Market Perform rating on EFR."
– Mark Reichman, Noble Capital Markets
"POE hit another high-impact well a little further away, called AA."
– Chen Lin, What Is Chen Buying? What Is Chen Selling?